Calogero Vetro

Arsenic trioxide and all-trans retinoic acid target NPM1 mutant oncoprotein levels and induce apoptosis in NPM1-mutated AML cells

Maria Paola Martelli, Ilaria Gionfriddo, Federica Mezzasoma et al. · Blood · 2015 · 143 citations · Full text

Circulating myeloid‐derived suppressor cells correlate with clinical outcome in Hodgkin Lymphoma patients treated up‐front with a risk‐adapted strategy

Alessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro et al. · British Journal of Haematology · 2014 · 91 citations · Full text

Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy

Alessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro et al. · Annals of Hematology · 2018 · 61 citations

Hematological Malignancy, Lymphoid Neoplasia, Prognostic Meaning +9

Novel <i>NPM1</i> exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML

Maria Paola Martelli, Roberta Rossi, Alessandra Venanzi et al. · Blood · 2021 · 53 citations · Full text

AVALON: The Italian cohort study on real‐life efficacy of hypomethylating agents plus venetoclax in newly diagnosed or relapsed/refractory patients with acute myeloid leukemia

Elisabetta Todisco, Cristina Papayannidis, Nicola Fracchiolla et al. · Cancer · 2023 · 43 citations · Full text